Evidence map›Paper›PMID 36026532›Full record

Trial reportEuropean heart journal. Quality of care & clinical outcomes2023

De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial.

Fayeza Ahmad, Rosie Fountotos, Michael Goldfarb, Neetika Bharaj, Haroon Munir, John Marsala, Lawrence G Rudski, Jonathan Afilalo

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European heart journal. Quality of care & clinical outcomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fayeza AhmadDivision of Experimental Medicine, McGill University, Montreal,QC H4A 3J1,Canada.ORCID 0000-0003-2949-0499
Rosie FountotosDivision of Experimental Medicine, McGill University, Montreal,QC H4A 3J1,Canada.ORCID 0000-0002-2429-5793
Michael GoldfarbDivision of Experimental Medicine, McGill University, Montreal,QC H4A 3J1,Canada.ORCID 0000-0001-9790-1232
Neetika BharajCentre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC H3T 1E2,Canada.
Haroon MunirDivision of Experimental Medicine, McGill University, Montreal,QC H4A 3J1,Canada.ORCID 0000-0002-9240-4568
John MarsalaDivision of Cardiology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2,Canada.
Lawrence G RudskiDivision of Cardiology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2,Canada.ORCID 0000-0003-1876-1492
Jonathan AfilaloDivision of Experimental Medicine, McGill University, Montreal,QC H4A 3J1,Canada.ORCID 0000-0003-0555-4937
Jewish General Hospital · CA

Funding

CIHR
6 · The paper itself

Abstract

aimsFrailty is disproportionately prevalent in cardiovascular disease patients and exacerbated during hospital admissions, heightening the risk for adverse events and functional decline. Using the Essential Frailty Toolset (EFT) to target physical weakness, cognitive impairment, malnourishment, and anaemia, we tested a multicomponent targeted intervention to de-frail older adults with acute cardiovascular conditions during their hospital admission. METHODS AND

resultsThe TARGET-EFT trial was a single-center randomized clinical trial at the Jewish General Hospital, Montreal, Canada. We compared a multicomponent de-frailing intervention with usual clinical care. Intervention group patients received exercise, cognitive stimulation, protein supplementation, and iron replacement, as required. In this study, the primary outcome was frailty, as assessed by the SPPB score (Short Physical Performance Battery) at discharge, and the secondary outcome was the SARC-F score (Strength, Assistance walking, Rising from chair, Climbing, Falls) assessed 30 days later. The analysis consisted of 135 patients (mean age of 79.3 years; 54% female) who survived and completed the frailty assessments.Compared with control patients, intervention group patients had a 1.52-point superior SPPB score and a 0.74-point superior SARC-F score. Subgroup analysis suggested that patients with low left ventricular ejection fraction may have attenuated benefits, and that patients who underwent invasive cardiac procedures had the greatest benefits from the intervention.

conclusionWe achieved our objective of de-frailing older cardiac inpatients on a short-term basis by improving their physical performance and functioning using a pragmatic multicomponent intervention. This could have positive impacts on their clinical outcomes and ability to maintain independent living in the future. ONE SENTENCE SUMMARY: The multicomponent intervention targeted to the deficits of vulnerable older adults hospitalized with acute cardiovascular diseases successfully de-frailed them on a short-term basis, which can have positive implications on their post-discharge health outcomes.

Indexed as

FrailtyAftercareAgedFemaleHumansMalePatient DischargeStroke VolumeVentricular Function, Leftcardiologyfrailtygeriatricsinterventionphysical performancerandomized clinical trial

Identifiers

PMID36026532
PMCPMC10405162
OpenAlexW4294619563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.